Zaviralec proteaz: Razlika med redakcijama

* [[HIV]]/[[aids]] (z značilno končnico '''-navir'''): [[protiretrovirusno zdravilo|protiretrovirusni]] zaviralci proteaz ([[amprenavir]], [[atazanavir]], [[darunavir]], [[fosamprenavir]], [[indinavir]], [[lopinavir]], [[nelfinavir]], [[ritonavir]], [[sakvinavir]], [[tipranavir]]<ref>Rang, H. P., Dale, M. M., Ritter, J. M., & Flower, R. J. (2007). Rang and Dale's Pharmacology (6th Edition ed.). Philadelphia: Churchill Livingstone Elsevier.</ref><ref name="Stem Book">{{cite web|title=The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances|url=http://www.who.int/medicines/services/inn/StemBook_2013_Final.pdf|publisher=World Health Organization|accessdate=5 November 2016}}</ref>{{rp|23}} etc.)